AGP Picks
View all

Technology News Journal
Provided by AGP

Technology News Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology News Journal.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on May 18, 2026

Certara to Participate in Upcoming Investor Conferences
May 18, 2026

Certara to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Latham Group, Inc. to Participate at Conferences in May and June 2026
May 18, 2026

Latham Group, Inc. to Participate at Conferences in May and June 2026

Indeterminate GlobeNewswire
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
May 18, 2026

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
GSI Technology Awarded Phase I of Smart City Project in Taiwan, Advancing Commercial Deployment of Gemini-II
May 18, 2026

GSI Technology Awarded Phase I of Smart City Project in Taiwan, Advancing Commercial Deployment of Gemini-II

Indeterminate GlobeNewswire
IES Holdings to Attend Upcoming Investor Conferences
May 18, 2026

IES Holdings to Attend Upcoming Investor Conferences

Indeterminate GlobeNewswire
Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference
May 18, 2026

Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire
Mineralys Therapeutics Announces Presentation of New Data from the Phase 3 Launch-HTN Trial of Lorundrostat at the 35th European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)
May 18, 2026

Mineralys Therapeutics Announces Presentation of New Data from the Phase 3 Launch-HTN Trial of Lorundrostat at the 35th European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)

Indeterminate GlobeNewswire
Matrix Service Company to Present at Upcoming Sidoti Virtual Micro-Cap Conference May 20-21, 2026
May 18, 2026

Matrix Service Company to Present at Upcoming Sidoti Virtual Micro-Cap Conference May 20-21, 2026

Indeterminate GlobeNewswire
AvePoint to Participate in Upcoming Investor Conferences 
May 18, 2026

AvePoint to Participate in Upcoming Investor Conferences 

Indeterminate GlobeNewswire
BGSF, Inc. Participating in the 16th Annual East Coast IDEAS Conference at The Westin New York at Times Square
May 18, 2026

BGSF, Inc. Participating in the 16th Annual East Coast IDEAS Conference at The Westin New York at Times Square

Indeterminate GlobeNewswire
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 18, 2026

C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 18, 2026

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Belite Bio Receives Orphan Drug Status for Tinlarebant in Stargardt Disease in Switzerland
May 18, 2026

Belite Bio Receives Orphan Drug Status for Tinlarebant in Stargardt Disease in Switzerland

Indeterminate GlobeNewswire
Toll Brothers Announces Cameron Cove Now Open in Marietta, Georgia
May 18, 2026

Toll Brothers Announces Cameron Cove Now Open in Marietta, Georgia

Indeterminate GlobeNewswire
DeGen Medical Expands Patient-Specific Spine Platform
May 18, 2026

DeGen Medical Expands Patient-Specific Spine Platform

Indeterminate GlobeNewswire
project44 Delivers 34% New ARR Growth Fueled by AI Agent Momentum and Intelligent TMS Expansion
May 18, 2026

project44 Delivers 34% New ARR Growth Fueled by AI Agent Momentum and Intelligent TMS Expansion

Indeterminate GlobeNewswire
Press Release: ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD  
May 18, 2026

Press Release: ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD  

Indeterminate GlobeNewswire
Communiqué de presse : ATS : Les données de phase 2 démontrent la supériorité de l'efdoralprin alfa par rapport au traitement de substitution standard pour atteindre des taux de fAAT plus élevés dans le DAAT
May 18, 2026

Communiqué de presse : ATS : Les données de phase 2 démontrent la supériorité de l'efdoralprin alfa par rapport au traitement de substitution standard pour atteindre des taux de fAAT plus élevés dans le DAAT

Indeterminate GlobeNewswire
Utility Global Launches European Market Expansion at World Hydrogen Summit 2026
May 18, 2026

Utility Global Launches European Market Expansion at World Hydrogen Summit 2026

Indeterminate EIN Presswire
Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
May 18, 2026

Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Technology News Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.